Drug intelligence / Profile preview

CheonWangBoSim-dan

Development stage
Phase 4
Lead developer
Korea Institute of Oriental Medicine
Administration
Oral, Topical
01

Overview

CheonWangBoSim-dan (also known as Tian Wang Bu Xin Dan or CWBSD) is a traditional East Asian herbal formula composed of 15 medicinal herbs, including *Rehmannia glutinosa*, *Coptis japonica*, *Acorus gramineus*, *Panax ginseng*, *Angelica gigas*, *Schisandra chinensis*, *Asparagus cochinchinensis*, *Liriope platyphylla*, *Thuja orientalis*, *Ziziphus jujuba*, *Scrophularia buergeriana*, *Poria cocos*, *Salvia miltiorrhiza*, *Platycodon grandiflorus*, and *Polygala tenuifolia*. It is widely used in South Korea and other East Asian countries as an over-the-counter (OTC) medicine to treat insomnia, anxiety, restlessness, palpitations, forgetfulness, and neurasthenia. In addition to its traditional uses, CheonWangBoSim-dan is being investigated for its potential therapeutic benefits in mild cognitive impairment (MCI), chronic pruritus, and chronic obstructive pulmonary disease (COPD). Its mechanisms of action include the inhibition of acetylcholinesterase (AChE) to improve cholinergic neurotransmission, the inhibition of IgE-FcεRI binding to suppress mast cell degranulation and histamine release, and the modulation of sensory neuronal activation.

Brand names
Anjeong LiquidAnjeong-aekCheonsimCheonsim CapsuleCheonsim LiquidCheonsim-aekDonginbosimdan-hwanEunpyeongsimdanEunsimdanGP CheongsimdanGeumwangsimdanGihwacheonggihwanGyeongjin CheonwangbosimdanHanjung JinsimdanJeongwoo Anshim LiquidJinjeong-hwanKwangdong Simryeok LiquidMyeongsimhwanNoksim-hwanPyeongsin LiquidPyeongsin-dan-hwanSedaphil LiquidSimbo-hwanSimyu-hwanSolpyo JeongsimwonSolpyo Jeongsimwon LiquidSoonsimhwanSunsimhwanTaepyeong-hwanWonkwang JinsimhwanYongcheonhwanYongchun PillYongpyo Anshin LiquidYongpyo Anshin Pill
Other names
CBDCBDWChunwangboshimdanCV3CV-3CV 3CWBSDTennohosintanTennou-hoshin-tanTian Wang Bu Xin DanTianwangbuxin-PelletTianwangbuxin-dan
02

Targets

AcetylcholinesteraseFCER1A (Fc epsilon receptor I alpha)IgE (Immunoglobulin E)CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on CheonWangBoSim-dan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CheonWangBoSim-dan.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call